JNK2 Antikörper
-
- Target Alle JNK2 (MAPK9) Antikörper anzeigen
- JNK2 (MAPK9) (Mitogen-Activated Protein Kinase 9 (MAPK9))
-
Reaktivität
- Human, Maus, Ratte, Hund, Affe
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser JNK2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC)
- Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
- Immunogen
- Full length human recombinant protein of human MAPK9(NP_620707) produced in HEK293T cell.
- Klon
- OTI2D11
- Isotyp
- IgG1
- Top Product
- Discover our top product MAPK9 Primärantikörper
-
anti-Mitogen-Activated Protein Kinase 9 (MAPK9) (AA 321-424) antibody
MAPK9 Reaktivität: Human WB, ELISA, IF, PLA Wirt: Maus Monoclonal 2F8 unconjugated
anti-Mitogen-Activated Protein Kinase 9 (MAPK9) (AA 321-424) antibodyMAPK9 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 1D6 unconjugated
anti-Mitogen-Activated Protein Kinase 9 (MAPK9) (AA 227-382) antibodyMAPK9 Reaktivität: Human WB, ELISA, FACS Wirt: Maus Monoclonal 2F6H11 unconjugated
anti-Mitogen-Activated Protein Kinase 9 (MAPK9) (AA 1-424) antibodyMAPK9 Reaktivität: Human WB, ELISA, IHC (p), RNAi Wirt: Maus Monoclonal 1C1-3A8 unconjugated
anti-Mitogen-Activated Protein Kinase 9 (MAPK9) antibodyMAPK9 Reaktivität: Human, Maus, Ratte, Hund, Affe WB, IHC, IF, IHC (p) Wirt: Maus Monoclonal 2G3 unconjugated
anti-Mitogen-Activated Protein Kinase 9 (MAPK9) (AA 130-387) antibodyMAPK9 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase 9 (MAPK9) (AA 1-424) antibodyMAPK9 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase 9 (MAPK9) (AA 349-379), (C-Term) antibodyMAPK9 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB2510 unconjugated
anti-Mitogen-Activated Protein Kinase 9 (MAPK9) antibodyMAPK9 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase 9 (MAPK9) antibodyMAPK9 Reaktivität: Human WB, IHC, IF, IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB 1:200~2000, IHC 1:150,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
-
- Target
- JNK2 (MAPK9) (Mitogen-Activated Protein Kinase 9 (MAPK9))
- Andere Bezeichnung
- MAPK9 (MAPK9 Produkte)
- Synonyme
- MAPK9 antikoerper, JNK-55 antikoerper, JNK2 antikoerper, JNK2A antikoerper, JNK2ALPHA antikoerper, JNK2B antikoerper, JNK2BETA antikoerper, PRKM9 antikoerper, SAPK antikoerper, SAPK1a antikoerper, p54a antikoerper, p54aSAPK antikoerper, AI851083 antikoerper, Prkm9 antikoerper, JNK2-ALPHA1 antikoerper, MAP kinase 9 antikoerper, mitogen-activated protein kinase 9 antikoerper, MAP kinase 9 antikoerper, MAPK9 antikoerper, Mapk9 antikoerper, MPK9 antikoerper
- Molekulargewicht
- 43.9 kDa
- NCBI Accession
- NM_139068
- HGNC
- 5601
- Pathways
- MAPK Signalweg, WNT Signalweg, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Endopeptidase Activity, Hepatitis C, Toll-Like Receptors Cascades, BCR Signaling, S100 Proteine
-
